Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$0.37 - $1.69 $40 - $185
-110 Reduced 8.11%
1,246 $0
Q2 2023

Aug 10, 2023

SELL
$0.39 - $1.69 $633 - $2,746
-1,625 Reduced 54.51%
1,356 $0
Q3 2022

Nov 15, 2022

BUY
$2.24 - $4.18 $3,360 - $6,270
1,500 Added 101.28%
2,981 $8,000
Q2 2022

Aug 09, 2022

BUY
$2.85 - $7.77 $741 - $2,020
260 Added 21.29%
1,481 $4,000
Q1 2022

May 09, 2022

SELL
$5.7 - $9.3 $16,929 - $27,621
-2,970 Reduced 70.87%
1,221 $9,000
Q4 2021

Feb 07, 2022

SELL
$8.73 - $15.27 $4,007 - $7,008
-459 Reduced 9.87%
4,191 $37,000
Q2 2021

Aug 13, 2021

SELL
$22.12 - $32.06 $2,742 - $3,975
-124 Reduced 2.6%
4,650 $112,000
Q1 2021

May 13, 2021

SELL
$26.12 - $52.17 $5,093 - $10,173
-195 Reduced 3.92%
4,774 $153,000
Q4 2020

Feb 02, 2021

SELL
$14.05 - $29.0 $16,129 - $33,292
-1,148 Reduced 18.77%
4,969 $122,000
Q3 2020

Nov 13, 2020

SELL
$14.17 - $19.48 $7,085 - $9,740
-500 Reduced 7.56%
6,117 $87,000
Q2 2020

Aug 13, 2020

BUY
$13.25 - $21.72 $7,155 - $11,728
540 Added 8.89%
6,617 $107,000
Q1 2020

May 13, 2020

BUY
$9.73 - $24.9 $28,577 - $73,131
2,937 Added 93.54%
6,077 $87,000
Q4 2019

Feb 14, 2020

BUY
$14.22 - $23.38 $14,106 - $23,192
992 Added 46.18%
3,140 $66,000
Q3 2019

Nov 13, 2019

SELL
$22.93 - $41.06 $68,308 - $122,317
-2,979 Reduced 58.1%
2,148 $49,000
Q2 2019

Aug 13, 2019

BUY
$38.73 - $52.03 $82,107 - $110,303
2,120 Added 70.5%
5,127 $207,000
Q1 2019

May 15, 2019

BUY
$28.11 - $50.77 $61,139 - $110,424
2,175 Added 261.42%
3,007 $130,000
Q4 2018

Feb 14, 2019

BUY
$26.22 - $56.89 $14,945 - $32,427
570 Added 217.56%
832 $22,000
Q3 2018

Nov 13, 2018

BUY
$24.31 - $52.74 $6,369 - $13,817
262 New
262 $13,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.05B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.